On the contrary, we demonstrated a positive correlation between G9A and the prognosis of psoriasis from clinical data and animal models, in which downregulating G9A accompanied with ameliorated psoriasis phenotype (Figs. 1, 2). This evidence concerns the gene EHMT2 and psoriasis.